Anthem (NYSE:ANTM) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 25.100- for the period, compared to the Thomson Reuters consensus estimate of $24.820. The company issued revenue guidance of $135.10 billion-$135.10 billion, compared to the consensus revenue estimate of $135.03 billion.

NYSE ANTM traded up $4.00 during trading on Tuesday, reaching $390.58. 44,417 shares of the stock traded hands, compared to its average volume of 1,298,946. The firm has a market cap of $95.63 billion, a price-to-earnings ratio of 20.11, a price-to-earnings-growth ratio of 0.92 and a beta of 1.00. The stock’s 50-day moving average price is $364.73 and its 200 day moving average price is $324.67. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.56. Anthem has a fifty-two week low of $244.10 and a fifty-two week high of $389.31.

Anthem (NYSE:ANTM) last released its quarterly earnings data on Tuesday, April 20th. The company reported $7.01 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $6.86 by $0.15. The firm had revenue of $32.10 billion for the quarter, compared to the consensus estimate of $32.98 billion. Anthem had a net margin of 4.22% and a return on equity of 18.45%. The company’s quarterly revenue was up 9.0% on a year-over-year basis. During the same period in the previous year, the company earned $6.48 earnings per share. Analysts anticipate that Anthem will post 22.44 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 25th. Shareholders of record on Thursday, June 10th will be paid a dividend of $1.13 per share. The ex-dividend date is Wednesday, June 9th. This is a boost from Anthem’s previous quarterly dividend of $0.95. This represents a $4.52 annualized dividend and a yield of 1.16%. Anthem’s dividend payout ratio (DPR) is 23.25%.

ANTM has been the subject of a number of recent analyst reports. Barclays lifted their target price on Anthem from $375.00 to $425.00 and gave the company an overweight rating in a report on Wednesday, April 28th. Cowen increased their target price on Anthem from $360.00 to $395.00 and gave the stock an outperform rating in a research note on Tuesday, April 20th. Truist Securities upped their price target on Anthem from $425.00 to $450.00 and gave the company a buy rating in a report on Tuesday, April 20th. Credit Suisse Group increased their target price on Anthem from $382.00 to $425.00 and gave the company an outperform rating in a report on Wednesday, April 28th. Finally, Stephens increased their target price on Anthem from $395.00 to $430.00 and gave the stock an overweight rating in a research report on Wednesday, April 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and sixteen have given a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus target price of $388.00.

In other news, EVP Peter D. Haytaian sold 59,500 shares of the business’s stock in a transaction on Monday, March 22nd. The shares were sold at an average price of $349.20, for a total transaction of $20,777,400.00. Following the completion of the sale, the executive vice president now directly owns 59,544 shares of the company’s stock, valued at approximately $20,792,764.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ryan M. Schneider acquired 1,700 shares of the stock in a transaction dated Thursday, February 4th. The shares were bought at an average cost of $296.03 per share, with a total value of $503,251.00. Following the completion of the purchase, the director now directly owns 2,921 shares in the company, valued at $864,703.63. The disclosure for this purchase can be found here. 0.22% of the stock is currently owned by insiders.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Further Reading: Hedge Funds – How They Work For Investors

Earnings History and Estimates for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.